Healthcare Sector

BMY

Market Tracker

  • BMY (Selected)

    Bristol-Myers Squibb Company

BMY Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

BMY Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

BMY Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

BMY Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
07/03/2025 CALL $48.50 13,362 +6,329 +89.99%
01/16/2026 CALL $57.50 4,299 +741 +20.83%
07/18/2025 PUT $46.00 1,460 +439 +43.00%
09/19/2025 CALL $50.00 5,895 +424 +7.75%
11/21/2025 CALL $52.50 2,071 +305 +17.27%
08/15/2025 CALL $52.50 14,282 +272 +1.94%
07/03/2025 CALL $48.00 1,309 -242 -15.60%
07/11/2025 CALL $46.50 12 -540 -97.83%
07/03/2025 CALL $47.00 0 -707 -100.00%
07/18/2025 CALL $45.00 116 -763 -86.80%
07/03/2025 CALL $46.50 0 -784 -100.00%
08/15/2025 CALL $40.00 87 -930 -91.45%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

BMY Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.07% 64.63M 4.03B
Vanguard 500 Index Fund 2.34% 49.15M 3.06B
Fidelity 500 Index Fund 1.11% 23.31M 1.45B
SPDR S&P 500 ETF Trust 1.09% 23.02M 1.43B
iShares Core S&P 500 ETF 0.90% 18.98M 1.18B
Vanguard Index-Value Index Fund 0.87% 18.37M 1.14B
JP Morgan Equity Income Fund 0.82% 17.35M 1.08B
Select Sector SPDR Fund-Health Care 0.82% 17.27M 1.08B
American Mutual Fund Inc 0.78% 16.49M 1.03B
Vanguard Institutional Index Fund-Institutional Index Fund 0.71% 14.9M 927.91M

BMY News

  • FDA Eases Rules For Bristol Myers' Cell Therapies For Blood Cancers

    06/27 11:34 am

    Benzinga

    Read more
  • 2 Beaten-Down Stocks to Avoid

    06/27 08:15 am

    The Motley Fool

    Read more
  • Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight

    06/24 01:00 pm

    GlobeNewswire Inc.

    Read more
  • ICPO Foundation ist Co-Founder der RLT Angels Association mit dem Ziel, den Zugang zur Radiotheranostik für eine Million PatientInnen auszubauen

    06/21 06:20 am

    GlobeNewswire Inc.

    Read more
  • ICPO Foundation co-founded the RLT Angels Association with the aim of growing access to Radiotheranostics to one million patients

    06/21 06:20 am

    GlobeNewswire Inc.

    Read more
  • Editas Medicine Is Great. Here's Why You Shouldn't Buy It.

    06/17 10:07 am

    The Motley Fool

    Read more
  • 2 Beaten-Down Dividend Stocks to Buy Right Now

    06/16 04:25 am

    The Motley Fool

    Read more
  • Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties

    06/10 05:55 pm

    GlobeNewswire Inc.

    Read more
  • Rheumatoid Arthritis Global Market Research Report 2025-2035: TNF Inhibitors, IL-6 Inhibitors, and JAK Inhibitors at the Forefront of Developing Biologic Therapies

    06/10 04:53 am

    GlobeNewswire Inc.

    Read more
  • Dilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsight

    06/05 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Epigenetics Market Anticipated to Achieve 11.8% CAGR

    06/03 01:31 pm

    GlobeNewswire Inc.

    Read more
  • Bristol Myers Inks $11 Billion Licensing Pact With BioNTech For Bispecific Cancer Drug

    06/02 10:14 am

    Benzinga

    Read more
  • Bispecific Antibody Drug Conjugates Clinical Trials Bispecific ADC Market Size Insight

    05/29 01:16 pm

    GlobeNewswire Inc.

    Read more
  • Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors

    05/27 09:00 am

    GlobeNewswire Inc.

    Read more
  • GlycoEra AG Raises $130 Million to Advance Novel Pipeline of Extracellular Protein Degraders for the Treatment of Autoimmune Diseases

    05/27 07:00 am

    GlobeNewswire Inc.

    Read more
  • Tubulis Achieves Key Milestone in BMS Strategic License Agreement as First Collaboration Tubutecan ADC Enters the Clinic

    05/20 05:00 am

    GlobeNewswire Inc.

    Read more
  • Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight

    05/12 01:00 pm

    GlobeNewswire Inc.

    Read more
  • U.S. Small Business Association Awards Renaissance Global Services Two Prestigious Honors

    05/09 07:00 am

    GlobeNewswire Inc.

    Read more
  • FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight

    05/06 03:21 pm

    Benzinga

    Read more
  • FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months

    05/02 03:37 pm

    Benzinga

    Read more
  • This High-Yield Pharma Stock Looks Like an Incredible Bargain

    04/30 06:45 am

    The Motley Fool

    Read more
  • Analysis of Cancer Immunotherapy Technologies and Global Markets to 2029 - Merck, Roche, Bristol-Myers Squibb Company, Johnson & Johnson Services, and AstraZeneca Dominate

    04/30 04:56 am

    GlobeNewswire Inc.

    Read more
  • 4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off

    04/26 06:05 pm

    The Motley Fool

    Read more
  • Bristol Myers Delivers Upbeat 2025 Forecast Despite China Tariffs Impact

    04/24 11:55 am

    Benzinga

    Read more
  • Thermo Fisher Beats Q1 Estimates, Lowers Full-Year Forecast As Tariffs And Costs Take A Toll

    04/23 04:49 pm

    Benzinga

    Read more
  • Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight-Loss Pill?

    04/15 07:39 am

    The Motley Fool

    Read more
  • These Large-Cap Stocks With China And EU Exposure Got Crushed In The One Of The Most Volatile Trading Week (Apr 7-Apr 11): Are These In Your Portfolio?

    04/13 11:33 am

    Benzinga

    Read more
  • Specialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights

    04/10 01:58 pm

    GlobeNewswire Inc.

    Read more
  • Biopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline

    04/10 05:59 am

    GlobeNewswire Inc.

    Read more
  • Is Vertex Pharmaceuticals Stock a Buy?

    04/08 09:45 am

    The Motley Fool

    Read more
  • Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide

    04/08 04:48 am

    GlobeNewswire Inc.

    Read more
  • MPYS Protein Stimulants Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 10+ Leading Players Wheeling the Therapeutics Landscape

    04/07 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Is Bristol Myers Squibb's High-Yielding Dividend Safe?

    04/02 05:40 am

    The Motley Fool

    Read more
  • Tumor-infiltrating Lymphocyte (TIL) Therapies Global Market Report 2025: 75+ Therapies are Under Development and 100+ Clinical Trials are Underway Globally

    04/01 02:44 pm

    GlobeNewswire Inc.

    Read more
  • Beat the S&P 500 With This Cash-Gushing Dividend Stock

    04/01 08:00 am

    The Motley Fool

    Read more
  • Why Pfizer Is My Largest Healthcare Position

    03/27 06:45 am

    The Motley Fool

    Read more
  • Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed

    03/21 12:31 pm

    Benzinga

    Read more
  • 5 Reasons the Schwab U.S. Dividend Equity ETF Is a Long-Term Buy for 2030 and Beyond

    03/17 07:45 am

    The Motley Fool

    Read more
  • Perspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 in Combination with Nivolumab in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma

    03/17 07:00 am

    GlobeNewswire Inc.

    Read more
  • 3 Stocks to Buy Amid Market Correction Triggered by Trump's Trade War

    03/14 07:40 am

    Investing.com

    Read more
  • Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal

    03/11 10:17 am

    Benzinga

    Read more
  • Bristol Myers Unveils Positive Phase 3 Results for Sotyktu in Psoriatic Arthritis

    03/10 12:54 pm

    Benzinga

    Read more
  • Global Prostate Cancer Market to Reach USD 29.2 Billion by 2035, Driven by Aging Population and Awareness | Future Market Insights, Inc.

    03/09 08:30 pm

    GlobeNewswire Inc.

    Read more
  • Acetylcholine Receptor Antagonists Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

    03/06 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Cancer Biomarkers Research Report 2024: Global Market Projected to Soar to USD 62.14 Billion by 2034, Driven by Technological Advancements and Increasing Demand for Early Detection

    03/06 05:55 am

    GlobeNewswire Inc.

    Read more
  • Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

    03/03 02:00 pm

    GlobeNewswire Inc.

    Read more
  • International Myeloma Foundation (IMF) Celebrates Myeloma Milestones for 2025 Myeloma Action Month

    03/01 09:45 am

    GlobeNewswire Inc.

    Read more
  • Got $200? 2 Healthcare Stocks to Buy and Hold Forever

    02/26 05:32 am

    The Motley Fool

    Read more
  • TALTZ’s Rapid Market Ascent Reflects its Unparalleled Ability to Transform the Treatment Landscape for Autoimmune Diseases | DelveInsight

    02/24 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Bristol Myers Colorectal Cancer Treatment Goes Under Priority FDA Review

    02/24 01:24 pm

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: